In the head and neck region, BRAF gene mutations are detected at a high frequency in ameloblastomas [3, 5, 6], and this was also confirmed not only by genetic analysis but also by immunohistochemistry using a BRAF V600E-mutant specific antibody [7–9]. Here, BRAF is linked to ameloblastoma.